SCHEMBL26527978

SCHEMBL26527978

CC(C)(C)OC(=O)NCc1ccc(-c2nc3n(n2)CCC(F)C3)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 3/20 0.44
▸ GPR119 Q8TDV5 1/20 0.41
▸ HDAC1 Q13547 3/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ GRM2 Q14416 1/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ BRD4 O60885 1/20 0.39
▸ IGF1R P08069 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.38
▸ HPN P05981 1/20 0.38
▸ ACACB O00763 2/20 0.38
▸ ACACA Q13085 2/20 0.38
▸ ATR Q13535 1/20 0.38
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ AKT1 P31749 1/20 0.37
▸ SDCBP O00560 1/20 0.37
▸ SDC2 P34741 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26528714 0.90 NAMPT (0.44) NAMPTGPR119HDAC1L3MBTL1GRM2
SCHEMBL26526564 0.90 NAMPT (0.44) NAMPTGPR119HDAC1L3MBTL1GRM2
SCHEMBL26527383 0.90 NAMPT (0.44) NAMPTGPR119HDAC1L3MBTL1GRM2
SCHEMBL26526412 0.89 NAMPT (0.42) NAMPTGPR119HDAC1L3MBTL1GRM2
SCHEMBL26527335 0.89 NAMPT (0.45) NAMPTGPR119HDAC1L3MBTL1GRM2
SCHEMBL26527148 0.88 NAMPT (0.41) NAMPTGPR119HDAC1L3MBTL1GRM2
SCHEMBL26527249 0.88 NAMPT (0.42) NAMPTGPR119HDAC1L3MBTL1GRM2
SCHEMBL26527553 0.88 NAMPT (0.41) NAMPTGPR119HDAC1L3MBTL1GRM2
SCHEMBL26528084 0.88 NAMPT (0.41) NAMPTGPR119HDAC1L3MBTL1GRM2
SCHEMBL26527518 0.85 NAMPT (0.45) NAMPTGPR119HDAC1L3MBTL1GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023073090-A1 IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS Janssen Sciences Ireland Unlimited Company (IE) 2023-05-04 — — WO disclosed
Send feedback